Skip to main content
. Author manuscript; available in PMC: 2009 Jun 1.
Published in final edited form as: Am J Med. 2008 Jun;121(6):475–483.e3. doi: 10.1016/j.amjmed.2008.01.047

Figure 3.

Figure 3

Proposed model of potential risk factors (> 50% of the study population) associated with osteonecrosis of the jaw among patients with no history of cancer receiving bisphosphonates for osteoporosis or Paget’s disease